XML 20 R27.htm IDEA: XBRL DOCUMENT v2.3.0.15
11. Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2011
Segment Reporting [Abstract] 
Information regarding industry segments
Information regarding industry segments for the three months ended September 30, 2011 and 2010 is as follows (in millions):

 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2011
$
171.5

 
$
341.3

 
$
3.7

 
2010
$
153.2

 
$
314.9

 
$
3.4

 
 
 
 
 
 
 
Segment profit
2011
$
12.5

 
$
49.5

 
$
0.5

 
2010
$
11.4

 
$
49.6

 
$
0.3


Information regarding industry segments for the nine months ended September 30, 2011 and 2010 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2011
$
495.9

 
$
1,016.5

 
$
10.9

 
2010
$
455.3

 
$
928.8

 
$
9.3

 
 
 
 
 
 
 
Segment profit
2011
$
25.6

 
$
144.1

 
$
1.1

 
2010
$
30.5

 
$
134.6

 
$
0.5

Reconciliation of segment profit to consolidated income before taxes
The following reconciles total segment profit to consolidated income before taxes (in millions):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2011
 
2010
 
2011
 
2010
Total segment profit
$
62.5

 
$
61.3

 
$
170.9

 
$
165.6

Foreign exchange losses, net
(6.3
)
 
(2.7
)
 
(12.1
)
 
(3.5
)
Net corporate operating, interest and other expense not allocated to segments
(0.9
)
 
(1.0
)
 
(2.8
)
 
(2.6
)
Other income (expense), net
0.5

 
0.3

 
5.9

 
3.6

Consolidated income before taxes
$
55.8

 
$
57.9

 
$
161.9

 
$
163.1